Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
RNS posted after hours:-
https://newsfilter.io/a/04fbc844a1bcbf0469ed8e0f17f692a2
The presentation is on Tuesday and available on live stream so we can watch live. Also being recorded so can view after on the 4D website.
Posted after closing stateside so should see RNS here at open. For what its worth there was some afterhours buying and the stock went up +2.21% in aftermarket on LBPS
All helps to create interest I guess
Do we not think it interesting that he released the RNS on the NASDAQ after close last night ready for the next NASDAQ session at open, 2.30pm our time yet did NOT release an RNS on the AIM.
I'm sure that you can't disadvantage one market over another, so is this RNS delayed because something is being posted alongside it or has Duncan plain forgot to update us or does he feel that UK investor support is so low that as this is a stateside event and doesn't concern us and we wont be interested anyhow?
Answers on a postcard....
Anyone invested in crypto mining stocks (particularly those with listings in North America) will be well aware of HCW. They have a pretty bad reputation with those shareholders for arranging placings with significant discounts + cheap warrants involved, and furthermore are rumoured to get involved in shorting games on those stocks.
https://hcwco.com/transactions/
Hence somewhat concerning to see this news of DDDD getting associated with HCW. Hope it’s purely investor relations related and there is not more news (transaction ?) coming here…..
Well you can ignore 28jaczar HCW are just a broker.
Most biotechs are involved with them
I now ignore Sangijuelas. He sent me some weird message when I started posting on here and I see he has made so many posts for (and against) 4D in the past few months that one can tell when he was holding stock because he was Rampy McRampface. When he is short (like now) he is El Pesimista. I only trust honest posters who don't frighten decent Private Investors into selling their stock for a £40,000+ loss the day before the market rises almost 10%. Shame on him. Although I haven't bought any more DDDD stock today, I am waiting for the next unfortunate Private Investor to lose their nerve so that I can buy some of their stock on the cheap. I stand by my prediction of a £1.30p price before the end of August. I have still only seen positive FACTUAL evidence on this stock recently. All the supposition just instills doubt and fear.
Let's see which of the below people think is true
I am someone who was long then sold at a loss to then go and short.
Or I am someone that doesn't actually know how to initiate a short nor is particularly interested in doing so. Someone that buys long with a 3-5 year time frame. Invested here for 4 years.
Someone who did frequently provide a positive outlook on the company resulting from a lot of in depth research. And, who felt that having seen 2 additional factors (the most recent 0518 results and the misrepresentation of cash available from loan funding) on top of other more minor orange flags, a previous assessment of the company prospects was changed.
Following on from this a difficult decision was made to sell at a loss and informed others that my view had changed.
If you go back through my posts you will see me say on various occasions that the 0518 results would be key as to whether this was a goer or not.
I also emphasised 2 other factors that have nothing to do with 4D. The biotech bear market and the daily manipulation of trades by shorters made possible by the low volumes.
So you can believe the conspiracy theory or you can see that someone who felt that their previous optimistic view was wrong and was admitting to a mistake.
I mean I think some people seriously need to grow up a bit.
Every day brokers and fund managers revise their views on companies.
So it shouldn't really be surprising that people that post here do as well.
Let’s not thank you
@ Sang. Why on earth would you possibly think that anyone is in the slightest interested in your views. You have lost TOTAL credibility on this BB.
If it helps, what you are is someone that couldn’t take the stress, lost their bottle and sold all their shares and is absolutely petrified that it was a bad decision and the SP could go ballistic. My advice is try and come to terms with your decision and stop looking at the SP. I honestly think it’s affecting your health mate.
I actually detached from my emotions and made a cold, clinical decision that went against my inner feelings.
I see a lot of appeals here to people to just believe, to have faith, which sound to me a lot more based on emotion than a reasoned position.
You lot believe that it's wonderful that 0518 achieved the Primary endpoint for RCC. Yet how many of you know what the Primary Endpoint even was? And what that means for the chances of getting the Keytruda combo approved?
I have no regrets and have benefitted from the opportunity to deploy cash elsewhere in the current extremely volatile markets that I would have been unable to do if I had been trapped in 32-36 up down trading here.
Well good for you. Now just FO and pay attention to your new investments. Bye
Thanks to getting out here I was able to snap up a bit of
Graphcore
Thought Machine
Form 3
Endomag
and Aiven
at a very good price for a 5 year hold
Am I bothered
Well go bombard those boards with your dribble!!!.
They're unlisted so they don't have anything on LSE
So I have to come here and keep things honest
Still waiting to find out what the Primary Endpoint was and why it was not really very meaningful..
I give up your green
What was the Primary Endpoint achieved Scrambler?
More importantly I called you out a long time ago as a 'swinger' whilst you were trying make out that you were the 4D guru.
Get a life and move on. You are not worthy of any further interaction.
Green boxed with the rest of the disingenuous muppets!
So you don't know. OK thanks for clearing that up.
Imagine investing in a biotech when you have not got a clue what's going on.
A green clown now - relax
Hi Sang, primary endpoint can be found on clinical trial page which I believe is clinical benefit that includes SD. Company's rns dated 23rd March, 22 has heading "MRx0518 + Keytruda - Primary endpoint met in RCC". Are you saying company is lying on rns?
No RP
I am saying that the wording on clinical trials is vague as it references signs of anti tumour activity.
Efficacy on the Second Endpoint of tumour reduction would have been much stronger indicator of success.
They also said the reason they were holding back 0518 data last year was because they wanted to release biomarker data at the same time.
But they didn't release any biomarker analysis.
@RPStock
Please don't engage with the pond life, waste of time.
You cant reason with the unreasonable
Take Care
Pork's
>70% of his posting history is on a stock he doesn't own.
That's all you need to know about the leech and his games.
on conf. call on 23rd March, the external expert was asked question somewhere towards end and he said for such late line patients instead of response rate, disease control or survival can be the biomarker.
I listened to it twice and I didn't hear that.
Are you sure?
None of the scientists 4D paid to appear posted anything on Twitter about it and they are all fairly active